Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequency of TERT Promoter Mutations in Prostate Cancer.

Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2015

Stoehr Robert, Taubert Helge, Zinnall Ulrike, Giedl Johannes, Gaisa Nadine T, Burger Maximilian, Ruemmele Petra, Hurst Carolyn D, Knowles Margaret A, Wullich Bernd, Hartmann Arndt

Abstract excerpt

OBJECTIVE: Recently, recurrent mutations within the core promoter of the human telomerase reverse transcriptase (TERT) gene generating consensus binding sites for ETS transcription factor family members were described in melanomas and other malignancies (e.g. bladder cancer, hepatocellular carcinoma). These mutations were discussed as early drivers for malignant transformation. In prostate cancer (PrCa) TERT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Paraffin Embedding

Share to Promoter Regions, Genetic

Share to Prostatic Neoplasms

Share to Sequence Analysis, DNA

Share to Telomerase

Source

Identifiers

PMID: 25997473
DOI: 10.1159/000381903

Genes

TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequency of TERT Promoter Mutations in Prostate Cancer.PMID 25997473Read ↗

<i>TERT</i> Core Promotor Mutations in Early-Onset Bladder CancerSemantic proximity Read ↗

TERT Promoter Mutations in Penile Squamous Cell Carcinoma: High Frequency in Non-HPV-related Type and Association With Favorable Clinicopathologic FeaturesSemantic proximity Read ↗

Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.Semantic proximity Read ↗

Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers.Semantic proximity Read ↗

TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features.Semantic proximity Read ↗

Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.Semantic proximity Read ↗

High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.Semantic proximity Read ↗

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.Semantic proximity Read ↗

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.Semantic proximity Read ↗

Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.Semantic proximity Read ↗

Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness.Semantic proximity Read ↗

Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.